Lifevantage Operating Margin 2012-2026 | LFVN
Current and historical operating margin for Lifevantage (LFVN) over the last 10 years. The current operating profit margin for Lifevantage as of March 31, 2026 is 4.75%.
| Lifevantage Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2026-03-31 | $0.20B | $0.01B | 3.06% |
| 2025-12-31 | $0.21B | $0.01B | 3.81% |
| 2025-09-30 | $0.23B | $0.01B | 4.80% |
| 2025-06-30 | $0.23B | $0.01B | 5.26% |
| 2025-03-31 | $0.22B | $0.01B | 5.86% |
| 2024-12-31 | $0.21B | $0.01B | 5.19% |
| 2024-09-30 | $0.20B | $0.01B | 3.57% |
| 2024-06-30 | $0.20B | $0.01B | 2.50% |
| 2024-03-31 | $0.21B | $0.01B | 2.44% |
| 2023-12-31 | $0.21B | $0.01B | 2.37% |
| 2023-09-30 | $0.21B | $0.01B | 2.35% |
| 2023-06-30 | $0.21B | $0.01B | 2.34% |
| 2023-03-31 | $0.21B | $0.00B | 1.42% |
| 2022-12-31 | $0.21B | $0.00B | 1.45% |
| 2022-09-30 | $0.21B | $0.00B | 1.95% |
| 2022-06-30 | $0.21B | $0.01B | 3.88% |
| 2022-03-31 | $0.21B | $0.01B | 6.67% |
| 2021-12-31 | $0.21B | $0.01B | 6.60% |
| 2021-09-30 | $0.22B | $0.02B | 8.68% |
| 2021-06-30 | $0.22B | $0.02B | 7.69% |
| 2021-03-31 | $0.23B | $0.02B | 7.11% |
| 2020-12-31 | $0.23B | $0.02B | 7.42% |
| 2020-09-30 | $0.23B | $0.02B | 6.93% |
| 2020-06-30 | $0.23B | $0.02B | 6.90% |
| 2020-03-31 | $0.23B | $0.02B | 6.99% |
| 2019-12-31 | $0.23B | $0.02B | 6.55% |
| 2019-09-30 | $0.23B | $0.01B | 5.31% |
| 2019-06-30 | $0.23B | $0.01B | 4.42% |
| 2019-03-31 | $0.22B | $0.01B | 3.57% |
| 2018-12-31 | $0.22B | $0.01B | 3.65% |
| 2018-09-30 | $0.21B | $0.01B | 4.29% |
| 2018-06-30 | $0.20B | $0.01B | 4.43% |
| 2018-03-31 | $0.20B | $0.01B | 3.50% |
| 2017-12-31 | $0.19B | $0.01B | 2.58% |
| 2017-09-30 | $0.19B | $0.00B | 2.06% |
| 2017-06-30 | $0.20B | $0.01B | 2.50% |
| 2017-03-31 | $0.20B | $0.01B | 3.47% |
| 2016-12-31 | $0.21B | $0.01B | 5.16% |
| 2016-09-30 | $0.22B | $0.01B | 6.02% |
| 2016-06-30 | $0.21B | $0.01B | 6.80% |
| 2016-03-31 | $0.20B | $0.01B | 6.06% |
| 2015-12-31 | $0.19B | $0.01B | 4.81% |
| 2015-09-30 | $0.18B | $0.01B | 4.92% |
| 2015-06-30 | $0.19B | $0.01B | 7.37% |
| 2015-03-31 | $0.20B | $0.02B | 8.46% |
| 2014-12-31 | $0.21B | $0.02B | 9.48% |
| 2014-09-30 | $0.22B | $0.02B | 10.23% |
| 2014-06-30 | $0.21B | $0.02B | 8.88% |
| 2014-03-31 | $0.21B | $0.02B | 7.14% |
| 2013-12-31 | $0.21B | $0.02B | 7.32% |
| 2013-09-30 | $0.21B | $0.01B | 4.85% |
| 2013-06-30 | $0.21B | $0.01B | 5.77% |
| 2013-03-31 | $0.20B | $0.02B | 8.96% |
| 2012-12-31 | $0.19B | $0.02B | 10.70% |
| 2012-09-30 | $0.16B | $0.02B | 15.09% |
| 2012-06-30 | $0.13B | $0.02B | 15.87% |
| 2012-03-31 | $0.10B | $0.02B | 15.63% |
| 2011-12-31 | $0.07B | $0.01B | 14.29% |
| 2011-09-30 | $0.05B | $0.01B | 13.46% |
| 2011-06-30 | $0.04B | $0.00B | 10.53% |
| 2011-03-31 | $0.03B | $0.00B | 7.41% |
| 2010-12-31 | $0.02B | 0 | 0.00% |
| 2010-09-30 | $0.02B | $0.00B | -26.67% |
| 2010-06-30 | $0.01B | $-0.01B | -63.64% |
| 2010-03-31 | $0.01B | $-0.01B | -133.33% |
| 2009-12-31 | $0.01B | $-0.01B | -185.71% |
| 2009-09-30 | $0.01B | $-0.01B | -166.67% |
| 2009-06-30 | $0.01B | $-0.01B | -140.00% |
| 2009-03-31 | $0.00B | $0.00B | -75.00% |
| 2008-12-31 | $0.00B | $0.00B | -50.00% |
| 2008-09-30 | $0.00B | $0.00B | -50.00% |
| 2008-06-30 | $0.00B | $0.00B | -50.00% |
| 2008-03-31 | $0.00B | $0.00B | -50.00% |
| 2007-12-31 | $0.00B | $0.00B | -50.00% |
| 2007-09-30 | $0.00B | $0.00B | -100.00% |
| 2007-06-30 | $0.01B | $-0.01B | -100.00% |
| 2007-03-31 | $0.01B | $-0.01B | -120.00% |
| 2006-12-31 | $0.01B | $-0.01B | -120.00% |
| 2006-09-30 | $0.01B | $-0.01B | -83.33% |
| 2006-06-30 | $0.01B | $0.00B | -57.14% |
| 2006-03-31 | $0.01B | $0.00B | -37.50% |
| 2005-12-31 | $0.01B | $0.00B | -42.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.053B | $0.229B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |